Tommy G Thompson
CIK 1324863 · Chairman · last filed 2026-03-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.38M
Companies
10
Total Filings
305
Lifetime Open-Market Net
-$13.40M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UTHR | Director | 16,680 | $548.27 | $9.15M | -$13.73M | 61 | 2026-03-26 |
| TXMD | Director | 37,491 | $2.29 | $85.9K | $310.4K | 31 | 2025-12-29 |
| HEALTHPEAK PROPERTIES, INC. (PEAK) Delisted | Director | 144,290 | $17.10 | $2.47M | $198.7K | 4 | 2025-05-28 |
| DOC | Director | 156,830 | $20.09 | $3.15M | $1.14M | 19 | 2024-03-01 |
| SCLXW | Director | — | $0.17 | — | $0 | 1 | 2023-01-17 |
| CENTENE CORP (CNTE) Delisted | Director | 287,334 | — | — | -$1.39M | 84 | 2022-01-04 |
| TYME TECHNOLOGIES, INC. (TYME) Delisted | Director | — | $0.31 | — | $0 | 3 | 2019-08-27 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | 144,801 | — | — | $30.2K | 10 | 2016-01-04 |
| Vyant Bio, Inc. (CGIX) Delisted | Director | 2,500 | $4.61 | $11.5K | $0 | 1 | 2013-10-15 |
| AGA Medical Holdings, Inc. (AGAM) Delisted | Director | 0 | — | — | $29.0K | 4 | 2010-11-18 |
Recent Filings · Page 23 of 31
305 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-08-23 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Buy (P) | +3,050 | $9.9K | EDGAR |
| 2011-07-06 | — | Grant (A) | — | $0 | |
| 2011-07-01 | — | Grant (A) | — | $0 | |
| 2011-07-01 | CENTENE CORP (CNTE) Delisted | Grant (A) | +978 | $35.0K | EDGAR |
| 2011-06-30 | UTHR | Grant (A) | — | $0 | EDGAR |
| 2011-05-03 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | +21,000 | $0 | EDGAR |
| 2011-04-27 | CENTENE CORP (CNTE) Delisted | Grant (A) | +3,110 | $100.0K | EDGAR |
| 2011-04-04 | — | Grant (A) | — | $0 | |
| 2011-04-01 | CENTENE CORP (CNTE) Delisted | Grant (A) | +1,069 | $35.0K | EDGAR |
| 2011-01-04 | — | Grant (A) | — | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.